| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.22 |
0.0003 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.0008 |
| mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.002 |